Nicole Gifford
IPRs Provide a Useful Alternative to Litigation for Challenging Key Patents
Biosimilars Law Bulletin ·
PTAB Institutes IPR filed by Celltrion for Rituximab Patent
Biosimilars Law Bulletin ·
Celltrion’s Truxima (rituximab) Approved in Europe
Biosimilars Law Bulletin ·
Celltrion Files IPR Petition on Herceptin® Patent
Biosimilars Law Bulletin ·
Genentech Sues Amgen Over BPCIA Disclosures for Avastin® (bevacizumab)
Biosimilars Law Bulletin ·